{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:56:38Z","timestamp":1761807398325},"reference-count":18,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":5250,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1993,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>OBJECTIVE Recent studies have suggested that patients receiving thyroxine are at increased risk of osteoporosis. We set out to measure bone mineral densities in two groups of post\u2010menopausal women receiving thyroxine replacement therapy (those with serum TSH levels persistently suppressed or non\u2010suppressed) and to compare the results in both groups with those of the local control population.<\/jats:p><jats:p>DESIGN Cross\u2010sectional study.<\/jats:p><jats:p>PATIENTS Seventy\u2010eight post\u2010menopausal women who had been treated with thyroxine for primary autoimmune or idiopathic hypothyroidism for a minimum of 5 years, 44 with TSH persistently suppressed and 34 non\u2010suppressed. One hundred and two control subjects.<\/jats:p><jats:p>MEASUREMENTS Forearm bone mineral density at proximal and distal sites as measured by single\u2010photon absorptiometry.<\/jats:p><jats:p>RESULTS Results were expressed as <jats:italic>Z<\/jats:italic>\u2010scores, i.e. number of standard deviations from the mean of a 5\u2010year age\u2010band from the local control population. Mean <jats:italic>Z<\/jats:italic>\u2010scores at proximal and distal sites for the non\u2010suppressed patients were \u2010003 and \u2010007 and for the suppressed patients were 0 20 and \u20100 25, representing a decrease in bone mineral density of at most 5% in the suppressed patients. The differences between the three groups were not statistically significant.<\/jats:p><jats:p>CONCLUSION In this patient population, the reduction in bone mineral density due to thyroxine is small. It is unlikely to be of clinical significance and should not on its own be an indication for reduction of thyroxine dose in patients who are clinically euthyroid.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1993.tb02404.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T11:07:00Z","timestamp":1205752020000},"page":"529-533","source":"Crossref","is-referenced-by-count":47,"title":["Suppressed TSH levels secondary to thyroxine replacement therapy are not associated with osteoporosis"],"prefix":"10.1111","volume":"39","author":[{"given":"David J.","family":"Grant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion E.T.","family":"McMurdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Mole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin R.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert R.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90577-K"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92900-3"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-6-1182"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-6-1184"},{"key":"e_1_2_1_6_1","first-page":"81","article-title":"Methods for measuring bone mineral density","volume":"7","author":"Eastell R.","year":"1990","journal-title":"Bone"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.300.6726.693"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92423-D"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90066-7"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1001\/jama.1991.03460200068037","article-title":"Bone mineral density in premenopausal women receiving long\u2010term physiological doses of levothyroxine","volume":"265","author":"Kung A.W.C.","year":"1991","journal-title":"JAMA"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0030-5898(20)30490-9","article-title":"Bony manifestations of thyrotoxicosis","volume":"3","author":"Meunier P.J.","year":"1972","journal-title":"Orthopedic Clinics of North America"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1001\/jama.1988.03720210027023","article-title":"Long\u2010term L\u2010thyroxine therapy is associated with decreased hip bone density in premenopausal women","volume":"259","author":"Paul T.L.","year":"1988","journal-title":"JAMA"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1990.tb00477.x"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90219-1"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90065-6"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-4-265"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03440110095035"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1990.tb00471.x"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1991.tb00278.x"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1993.tb02404.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1993.tb02404.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T10:50:06Z","timestamp":1698231006000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1993.tb02404.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,11]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1993,11]]}},"alternative-id":["10.1111\/j.1365-2265.1993.tb02404.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1993.tb02404.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,11]]}}}